Pancoast tumor imaging findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Pancoast tumor}}
{{Pancoast tumor}}
{{CMG}}{{AE}}{{Mazia}}
{{CMG}}; {{AE}} {{Mazia}}
==Overveiw==
==Overveiw==
A bone scan may demonstrate bone metastases. [[Fluorodeoxyglucose|FDG]](18 F fluoro deoxyglucose) [[Positron emission tomography|PET scans]] along with [[contrast enhanced CT]] may be helpful in the diagnosis of extent of Pancoast tumor.  
A [[bone scan]] may demonstrate [[bone metastases]]. [[Fluorodeoxyglucose|FDG]](18 F fluoro deoxyglucose) [[Positron emission tomography|PET scans]] along with [[contrast enhanced CT]] may be helpful in the [[diagnosis]] of extent of Pancoast tumor.  
==Other Imaging Findings==
==Other Imaging Findings==
===Bone Scintigraphy===
===Bone Scintigraphy===
A bone scan may demonstrate bone metastases.
A [[bone scan]] may demonstrate [[Bone metastases|bone metastases.]]
===PET scan===
===PET scan===
*[[Fluorodeoxyglucose|FDG]](18 F fluoro deoxyglucose) [[Positron emission tomography|PET scans]] along with [[contrast enhanced CT]] may be helpful in the diagnosis of extent of Pancoast tumor. Findings on FDGPET/CT suggestive of Pancoast tumor include:<ref name="PurandareRangarajan2015">{{cite journal|last1=Purandare|first1=NilenduC|last2=Rangarajan|first2=Venkatesh|title=Imaging of lung cancer: Implications on staging and management|journal=Indian Journal of Radiology and Imaging|volume=25|issue=2|year=2015|pages=109|issn=0971-3026|doi=10.4103/0971-3026.155831}}</ref>
*[[Fluorodeoxyglucose|FDG]] (18 F fluoro deoxyglucose) [[Positron emission tomography|PET scans]] along with [[contrast enhanced CT]] may be helpful in the [[diagnosis]] of extent of Pancoast tumor. Findings on FDGPET/CT suggestive of Pancoast tumor include:<ref name="PurandareRangarajan2015">{{cite journal|last1=Purandare|first1=NilenduC|last2=Rangarajan|first2=Venkatesh|title=Imaging of lung cancer: Implications on staging and management|journal=Indian Journal of Radiology and Imaging|volume=25|issue=2|year=2015|pages=109|issn=0971-3026|doi=10.4103/0971-3026.155831}}</ref>
**Solitary pulmonary nodule
**[[Solitary pulmonary nodule]]
*Benefits of FDGPET/CT include:<ref name="van BaardwijkBaumert2006">{{cite journal|last1=van Baardwijk|first1=Angela|last2=Baumert|first2=Brigitta G.|last3=Bosmans|first3=Geert|last4=van Kroonenburgh|first4=Marinus|last5=Stroobants|first5=Sigrid|last6=Gregoire|first6=Vincent|last7=Lambin|first7=Philippe|last8=De Ruysscher|first8=Dirk|title=The current status of FDG–PET in tumour volume definition in radiotherapy treatment planning|journal=Cancer Treatment Reviews|volume=32|issue=4|year=2006|pages=245–260|issn=03057372|doi=10.1016/j.ctrv.2006.02.002}}</ref>
*Benefits of FDGPET/CT include:<ref name="van BaardwijkBaumert2006">{{cite journal|last1=van Baardwijk|first1=Angela|last2=Baumert|first2=Brigitta G.|last3=Bosmans|first3=Geert|last4=van Kroonenburgh|first4=Marinus|last5=Stroobants|first5=Sigrid|last6=Gregoire|first6=Vincent|last7=Lambin|first7=Philippe|last8=De Ruysscher|first8=Dirk|title=The current status of FDG–PET in tumour volume definition in radiotherapy treatment planning|journal=Cancer Treatment Reviews|volume=32|issue=4|year=2006|pages=245–260|issn=03057372|doi=10.1016/j.ctrv.2006.02.002}}</ref>
**Accurate delineation of the viable tumor from surrounding [[atelectasis]] and [[Collapsed lung|collapse]] or [[Consolidation (medicine)|consolidation]].
**Accurate delineation of the viable [[tumor]] from surrounding [[atelectasis]] and [[Collapsed lung|collapse]] or [[Consolidation (medicine)|consolidation]].
**It may further lead to a change in staging and treatment options of the lung cancer.
**It may further lead to a change in [[Staging (pathology)|staging]] and [[Treatments|treatment]] options of the [[lung cancer]].
**Provide guidance for the [[biopsy]].<ref name="PurandareKulkarni2013">{{cite journal|last1=Purandare|first1=Nilendu C.|last2=Kulkarni|first2=Aniruddha V.|last3=Kulkarni|first3=Suyash S.|last4=Roy|first4=Diptiman|last5=Agrawal|first5=Archi|last6=Shah|first6=Sneha|last7=Rangarajan|first7=Venkatesh|title=18F-FDG PET/CT-directed biopsy|journal=Nuclear Medicine Communications|volume=34|issue=3|year=2013|pages=203–210|issn=0143-3636|doi=10.1097/MNM.0b013e32835c5a57}}</ref>
**Provide guidance for the [[biopsy]].<ref name="PurandareKulkarni2013">{{cite journal|last1=Purandare|first1=Nilendu C.|last2=Kulkarni|first2=Aniruddha V.|last3=Kulkarni|first3=Suyash S.|last4=Roy|first4=Diptiman|last5=Agrawal|first5=Archi|last6=Shah|first6=Sneha|last7=Rangarajan|first7=Venkatesh|title=18F-FDG PET/CT-directed biopsy|journal=Nuclear Medicine Communications|volume=34|issue=3|year=2013|pages=203–210|issn=0143-3636|doi=10.1097/MNM.0b013e32835c5a57}}</ref>
{| class="wikitable"
{| class="wikitable"
|[[Image:IJRI-25-109-g006.jpg|thumb|300px|Role of FDG PET/CT in primary tumor delineation. Irregular soft tissue opacity seen on coronal CT scan (arrow, A) with no obvious demarcation between the tumor and surrounding consolidation. PET/CT shows the FDG-avid tumor (arrow, B) separate from the non–FDG-avid consolidation (arrowhead, B),via <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419420/figure/F6/><ref name="PurandareRangarajan2015">{{cite journal|last1=Purandare|first1=NilenduC|last2=Rangarajan|first2=Venkatesh|title=Imaging of lung cancer: Implications on staging and management|journal=Indian Journal of Radiology and Imaging|volume=25|issue=2|year=2015|pages=109|issn=0971-3026|doi=10.4103/0971-3026.155831}}</ref>]]
|[[Image:IJRI-25-109-g006.jpg|thumb|300px|Role of FDG PET/CT in primary tumor delineation. Irregular soft tissue opaciseeisare seenn on coronal CT scan (arrow, A) with no obvious demarcation between the tumor and surrounding consolidation. PET/CT shows the FDG-avid tumor (arrow, B) separate from the non–FDG-avid consolidation (arrowhead, B),via https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419420/figure/F6/<ref name="PurandareRangarajan2015">{{cite journal|last1=Purandare|first1=NilenduC|last2=Rangarajan|first2=Venkatesh|title=Imaging of lung cancer: Implications on staging and management|journal=Indian Journal of Radiology and Imaging|volume=25|issue=2|year=2015|pages=109|issn=0971-3026|doi=10.4103/0971-3026.155831}}</ref>]]
|}
|}



Latest revision as of 18:11, 16 March 2018


Pancoast tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pancoast tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pancoast tumor imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pancoast tumor imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pancoast tumor imaging findings

CDC onPancoast tumor imaging findings

Pancoast tumor imaging findings in the news

Blogs on Pancoast tumor imaging findings

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pancoast tumor imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]

Overveiw

A bone scan may demonstrate bone metastases. FDG(18 F fluoro deoxyglucose) PET scans along with contrast enhanced CT may be helpful in the diagnosis of extent of Pancoast tumor.

Other Imaging Findings

Bone Scintigraphy

A bone scan may demonstrate bone metastases.

PET scan

Role of FDG PET/CT in primary tumor delineation. Irregular soft tissue opaciseeisare seenn on coronal CT scan (arrow, A) with no obvious demarcation between the tumor and surrounding consolidation. PET/CT shows the FDG-avid tumor (arrow, B) separate from the non–FDG-avid consolidation (arrowhead, B),via https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419420/figure/F6/[1]

References

  1. 1.0 1.1 Purandare, NilenduC; Rangarajan, Venkatesh (2015). "Imaging of lung cancer: Implications on staging and management". Indian Journal of Radiology and Imaging. 25 (2): 109. doi:10.4103/0971-3026.155831. ISSN 0971-3026.
  2. van Baardwijk, Angela; Baumert, Brigitta G.; Bosmans, Geert; van Kroonenburgh, Marinus; Stroobants, Sigrid; Gregoire, Vincent; Lambin, Philippe; De Ruysscher, Dirk (2006). "The current status of FDG–PET in tumour volume definition in radiotherapy treatment planning". Cancer Treatment Reviews. 32 (4): 245–260. doi:10.1016/j.ctrv.2006.02.002. ISSN 0305-7372.
  3. Purandare, Nilendu C.; Kulkarni, Aniruddha V.; Kulkarni, Suyash S.; Roy, Diptiman; Agrawal, Archi; Shah, Sneha; Rangarajan, Venkatesh (2013). "18F-FDG PET/CT-directed biopsy". Nuclear Medicine Communications. 34 (3): 203–210. doi:10.1097/MNM.0b013e32835c5a57. ISSN 0143-3636.

Template:WH Template:WS